MARIA RIVAROLA: Open Payments
NPI 1467905117 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 47 payments from 13 companies in 2025. Trend: 2023 $328 · 2024 $744 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $240 |
| ABBVIE INC. | 10 | $179 |
| Novo Nordisk Inc | 6 | $114 |
| PFIZER INC. | 6 | $100 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: MOUNJARO, VRAYLAR, UBRELVY, TRELEGY ELLIPTA, Wegovy, ELIQUIS, Ozempic, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
